The Company is a Korea-based company mainly engaged in the manufacturing and sale of stents. Stents include biliary, esophagus, pyloric, large intestine, duodenal stents, and stents for sample and study, among others. The Company's stents are sold under the brand names of CHOOSTENT and HANAROSTENT. In addition, the Company is engaged in the manufacture and sale of low frequency therapies, crushers and blood glucose meters. The Company distributes its products within the domestic market and to overseas markets. The Company was established on April 01, 1991. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on November 29, 2018.
Headquarters
174, Habuk 2-Gil, Jinwi-Myeon, Pyeongtaek-Si, Gyeonggi-Do
Pyeongtaek; Gyeonggi;
Contact Details: Purchase the Mitech Co.,Ltd. report to view the information.
Website: http://www.mitech.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service